In a decisive move, Delhi Health Minister Saurabh Bharadwaj, along with the Directorate of Vigilance, instructs State Health Secretary SB Deepak to promptly recall five substandard drugs. The identified drugs—amlodipine, levetiracetam, pantoprazole, cephalexin, and dexamethasone—must be withdrawn from the supplied stocks.
Prioritizing Drug Quality
Emphasizing the critical need for vigilance, Bharadwaj underscores the importance of ensuring drugs and consumables procured through the central procurement agency and GeM meet standard quality. This action aims to safeguard public health and maintain the integrity of the healthcare system.
The Hindustan Herald Is Your Source For The Latest In Business, Entertainment, Lifestyle, Breaking News, And Other News. Please Follow Us On Facebook, Instagram, Twitter, And LinkedIn To Receive Instantaneous Updates. Also Don’t Forget To Subscribe Our Telegram Channel @hindustanherald
